IPwe announced a new partnership with Open Therapeutics

IPwe and Open Therapeutics have concluded an Intellectual Property Partnership. 

Open Therapeutics is an open science company, in which IPwe will encourage innovation for the client of the ecosystem by identifying possible patent monetization opportunities in clients’ patent portfolios.

IPwe’s Senior Innovation Director Harry Stacpoole stated, « Over 80% of Open Therapeutics’ clients’ patents are currently not being licensed despite having potential opportunities for patent monetization. Through our partnership with Open Therapeutics, we can offer their member companies, governments, academic and research institutions the chance to license their unused patents while advancing on our own mission to encourage innovation by providing a mechanism for them to do so ».

Read full press release here